BISC Global, an international bioinformatics consulting company with offices in Belgium, USA (Boston and San Francisco) and Switzerland, was awarded a five hundred thousand euro research and development grant through Eurostars. Together with several European partners, BISC Global will support the development of a new vaccine against African Swine Fever (ASF).
ASF is a fatal infectious disease in pigs, which has resulted in the death of over 200 million pigs in the last 13 years and for which currently no vaccine is available. Within the consortium, the goal is to combine the power of big data analysis and Artificial Intelligence (AI) with an innovative virus-like particles (VLPs) vaccine platform to identify the right antigens and deliver proof of concept vaccine candidates for the circulating ASFV variant. This approach will also pave the way to develop vaccines for other viruses in the future.
According to Maarten Braspenning, CEO at BISC Global, “We are very excited to announce that we have received EUROSTARS funding for this project. This will enable the consortium to develop a new vaccine against ASF, which poses a huge treat to the global agriculture business. It will also enable BISC Global to build machine-learning based algorithms for antigen discovery and T-cell epitope prediction. By using machine learning and AI in this field, BISC Global believes it can bring enormous added value in vaccine development and immunology research.”
Founded in 2017, BISC Global has grown to be a Top 10 Bioinformatics Consulting and Services Firm supporting world’s leading pharmaceutical and biotech companies. Through our offices in Ghent, Belgium; Basel, Switzerland; Boston, MA; and San Francisco, CA; BISC Global provides data-analytics, custom tool/pipeline development, and cloud solutions delivered on-site or remotely. By leveraging our global workforce of expert consultants, we support analysis across multiple domains, including machine learning (data mining, pattern recognition, image analysis, (un)supervised learning, neural networks, deep learning, etc.), bioinformatics (single-cell transcriptomics, metabolomics, metagenomics, epigenomics, etc.), and statistics (experimental design, mathematic modelling, signal-to-noise enhancement, and independent data cross validation).